Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Frontline Plc (NY: FRO )

19.39 -0.10 (-0.51%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Frontline Plc

< Previous 1 2 3 4 5 6 7 Next >
FedEx Reports Downbeat Results, Joins MillerKnoll And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday
Via Benzinga
Frontline Navigates Choppy Waters: Q2 Revenue Soars, But EPS Sinks In Spicy Tanker Market
Frontline reported Q2 FY24 revenue of $607.5 million, beating consensus. Net operating income improved, but adjusted EPS missed consensus. 
Via Benzinga
Dow Notches New Record Close But Nasdaq Falls Amid Decline In Nvidia Shares: Fear Index Enters 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Exploring FRONTLINE PLC's Technical Signals and Breakout Potential.
A technical analysis of FRONTLINE PLC (NYSE:FRO) shows it may be setting up for a breakout. 
Via Chartmill
FRONTLINE PLC is showing promising signs of setting up for a breakout.
NYSE:FRO may be ready to breakout. 
Via Chartmill
Deep Dive Into Frontline Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Top Wall Street Forecasters Revamp Frontline Price Expectations Ahead Of Q2 Earnings
Via Benzinga
CrowdStrike Outage Hits Airlines, Global Travel, But Shipping Seems Unaffected
The update glitch has caused a global IT outage causing massive disruptions worldwide. 
Via Investor's Business Daily
The 3 Most Undervalued Oil & Gas Stocks to Buy in July 2024
Global oil prices have rallied since the start of the current year, but there are still undervalued oil & gas stocks to look into. 
Via InvestorPlace
Hot Stocks: 3 Untapped Opportunities for a 1,000% Return
Unlock high-return stock opportunities with solid fundamentals and market strategies in the oil and gas and technology sector. 
Via InvestorPlace
Contrarian Crusaders: 3 Stocks Championing the Cause of Unconventional Gains
Not every successful stock in the market has to be a household name or a major player in artificial intelligence. 
Via InvestorPlace
Forecasting The Future: 4 Analyst Projections For Frontline
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
NYSE:FRO, a strong growth stock, setting up for a breakout.
Exploring the Growth Potential of FRONTLINE PLC (NYSE:FRO) as It Nears a Breakout. 
Via Chartmill
Despite its impressive fundamentals, NYSE:FRO remains undervalued.
FRONTLINE PLC (NYSE:FRO), an undervalued stock with good fundamentals. 
Via Chartmill
3 Hidden-Gem Stocks That Everyone Should Own Now
The Nasdaq has rallied more than 13% so far this year, but several hidden-gems have yet to grab investors' attention. 
Via InvestorPlace
FRO Stock Earnings: Frontline Misses EPS, Beats Revenue for Q1 2024
FRO stock results show that Frontline missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Bargain Stocks Ready to Supercharge Your Wealth
Discover how the three bargain stocks operating in oil and gas transportation and financial sectors can turbocharge the portfolio's growth. 
Via InvestorPlace
3 Stocks About to Explode on Wall Street’s Radar
Three treasures are likely to attract Wall Street's interest and provide intelligent investors with considerable rewards. 
Via InvestorPlace
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
NYSE:FRO is showing good growth, while it is not too expensive.
Investors seeking growth at a reasonable cost should explore FRONTLINE PLC (NYSE:FRO). 
Via Chartmill
Hidden Treasures: 3 Stocks Poised for 10X Returns by 2027
Discover the untapped potential of three stocks poised for exponential growth, presenting opportunities of 10X returns in portfolios. 
Via InvestorPlace
The 3 Most Undervalued Under-$50 Stocks to Buy in April 2024
The U.S. stock market rally in 2024 has created relatively expensive equities, but there are still bargains to be had. 
Via InvestorPlace
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
The Nasdaq is on the cusp of setting a record high. 
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Frontline Outperforms Q4 Revenue Estimates; Strategic Asset Sales And Refinancing Bolster Financial Position
Frontline Plc reported Q4 revenue of $415M, beating consensus of $270.06M. Net income, EPS, and cash flow all decreased compared to last year. 
Via Benzinga
3 Ultra-High-Yield Dividend Stocks That Are Proven Wealth Creators
These three dividend stocks have been big winners for their shareholders. 
Via The Motley Fool
3 Life-Changing Stocks Poised for Phenomenal Growth
Discover how these life-changing stocks forge paths in energy, transportation and semiconductors for transformative valuations. 
Via InvestorPlace
Here Is Why Gold Stocks Are Performing Poorly
Gold has been going sideways now for several months with resistance at $2100 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.